Acadia Healthcare Company (ACHC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
25 Mar, 2026Executive summary
Annual meeting scheduled for May 6, 2026, with voting available online or in person.
Shareholders are encouraged to review proxy materials and vote by May 5, 2026.
Voting matters and shareholder proposals
Election of three directors: Michael J. Fucci, Patrice A. Harris, M.D., M.A., and Daniel J. Cancelmi, all recommended by the board.
Approval sought for a second amendment to the Amended and Restated Incentive Compensation Plan.
Advisory vote on executive compensation (say-on-pay) included.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Proxies may vote on other business as may properly come before the meeting.
Board of directors and corporate governance
Board recommends all director nominees for election.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Acadia Healthcare Company
- 2026 guidance targets $3.37B–$3.45B revenue, with growth driven by new bed ramp-up and cost discipline.ACHC
47th Annual Raymond James Institutional Investor Conference26 Mar 2026 - Proxy covers director elections, incentive plan amendment, say-on-pay, and auditor ratification.ACHC
Proxy filing25 Mar 2026 - Operational focus shifts to filling new beds, managing policy headwinds, and reducing debt.ACHC
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Organizational changes and cost controls aim to boost growth as CapEx drops and debt reduction takes priority.ACHC
Leerink Global Healthcare Conference 20269 Mar 2026 - 2026 guidance targets revenue growth, lower CapEx, and operational focus amid regulatory headwinds.ACHC
Q4 202525 Feb 2026 - Q2 revenue up 8.8% to $796M, net income $78.5M, and growth continues despite facility closures.ACHC
Q2 20242 Feb 2026 - Q3 revenue up 8.7% to $815.6M; 2024 guidance revised after facility closures and media scrutiny.ACHC
Q3 202417 Jan 2026 - Bed expansion, operational gains, and technology investments drive future growth.ACHC
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026 - Expansion and funding remain strong despite temporary volume moderation and increased scrutiny.ACHC
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026